Charles Darwin University (CDU) researchers have maintained their international reputations as some of the most influential in the world.
According to a Stanford University study, there were 22 academics from CDU and Menzies School of Health research who ranked in the top two per cent of researchers referenced in their respected disciplines for 2020.
The Stanford University and Elsevier BV study, which tallies the citation, references, and authorships of more than 100,000 past and present researchers, was updated at the end of October and published in the journal PLOS Biology.
Last year, the University had 21 academics in the upper echelon of influential researchers.
The researchers to achieve the top gongs this year were from a wide variety of fields, including ecology, network and communication, microbiology, nursing, environmental engineering, tropical medicine, and accounting.
CDU Professor of Accounting Indra Abeysekera said making the top two per cent in the accounting field and the broader area of business management was extremely challenging.
“Accounting is a profession, and there is the emphasis that research must impact the wider group of stakeholders,” Professor Abeysekera said.
“Before joining academia, I worked in the private and public sectors, had an experiential appreciation of stakeholder issues, and conducted empirically sound research that impacts stakeholders.”
Professor Abeysekera has been on the list in previous years, but for CDU Professor in Mental Health Daniel Bressington, this is the first time making the list of the most influential researchers.
Professor Bressington said making the list for the first time was a privilege.
“It’s difficult to get into the top two per cent. In this discipline there are many researchers who are known around the world; therefore, your research outputs need to be of excellent quality in order to make an impact,” Professor Bressington said.
Professor Bressington contributes his time and expertise to journals that publish mental health research, including as an academic editor at Plos One (clinical trials), associate editor at Frontiers in Psychiatry, and an
